Degradation products having various grades of molecular weight were derived from fibrinogen by plasmin action. A highly purified anticoagulant active substance was obtained by the combined use of ammonium sulfate fractionation and column chromatography on DEAE-cellulose. This sub stance has the ability to inhibit completely the clotting of whole blood in a concentration of 1-1.5%, to prolong the thrombin clotting time, and to produce a macroscopically and interference-phase-contrast-microscopically abnormal clot structure. Positive eephalin-cholesterol flocculation test was also observed by adding the digest products to serum.
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It is a well known fact that purified fibrinogen solution becomes resistant to the clotting activity of thrombin in varied speeds, depending on temperature of the reaction and purity of the preparation.
Seegers, Nieft and Vandenbelt1) separat ed at least two components which showed an electrophoretically different behavior and they concluded this might have resulted from a contamination with plasmin1). Niewiarowski and Kowalski2), and Triantaphyllopoulos3) separated a partially purified antithrombin substance from the digest products of fibrinogen by plasmin. Recently Fletcher, et al. 4, 5) and Bang et al. 6 ) gave detailed reports on the fibrinogen breakdown products which gave an increase of thrombin time, and a macroscopically and electron-microscopically abnormal clot structure of fibrin. This paper describes the preparation method of purified substance by using ammonium sulfate fractionation and column chromatography on DEAE-cellulose.
Furthermore, some properties of the substance are discussed.
MATERIALS AND METHODS
Purification of fibrinogen
To 5% solution of crude bovine (Armour) and human (Nippon Blood Bank) 
Ninhydrin reactions8
Reagents: Fibrinogen solution or plasma converts to fibrin with a jelly-like structure by adding thrombin. However, this jelly-like structure became loose, not jelly like, with a flocculous precipitate and finally non-clottable by adding increasing amounts of the digest product. Fig. 9 shows the fibrin clot structure of normal plasma formed by thrombin addition in the presence or absence of the digest product.
The CCF-test was always positive in all of the authors' 18 cases of obstetrical and surgical hypofibrinogenemia. In order to clarify this mechanism, various amounts of the digest products were added to serum, and then the CCF-test was performed. Addition of such large amounts of the digest products, over 1 mg per 0.1 ml. of serum, could produce a positive reaction. It is, however, uncertain whether such a high level of the digest products in the serum can be seen in actual clinical cases.
DISCUSSION
As presented in the above experiment , the digest products of fibrinogen by plasmin could be divided into 3 main fractions by chromatography, high and 
